Advertisement
On May 12, a 7.9-magnitude quake struck in Wen Chuan Sichuan provinceChina and toppled schools, apartment buildings and factories. Thousands ofpeople were killed or trapped in mounds of concrete, steel and earth in thecountry's worst quake in three decades. China Pharma quickly reacted to thetragedy and made a donation of medicines to the earthquake-hit areas starvingfor help. Meanwhile, every employee of China Pharma is actively makingdonations for the survivors of this devastating earthquake in Sichuan.
Advertisement
"I am extremely shocked and saddened by the extent of the destructioncaused by this earthquake in Sichuan Province. Our company and our employeesfeel a profound sympathy for the people suffering from this terrible tragedyat this time, and we are offering our support to these people and theirfamilies and sincerely hope that they could rebuild their homes in the nearfuture," Ms. Zhilin Li, President and CEO of China Pharma Holdings, Inc. said.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets genericand brand bio-pharmaceutical products in China that treat a wide range ofconditions, including infections, hepatitis, cardiovascular and CNS diseases,and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson),a specialty pharmaceutical company headquartered in Haikou City, Hainanprovince in China, is a wholly owned subsidiary of China Pharma Holdings. Formore information about China Pharma Holdings, Inc., please visithttp://www.chinapharmaholdings.com .
Safe Harbor Statement:
Certain statements in this press release and oral statements made by ChinaPharma on its conference call in relation to this release constitute forward-looking statements for purposes of the safe harbor provisions under ThePrivate Securities Litigation Reform Act of 1995. Any statements set forthabove that are not historical facts are forward-looking statements thatinvolve risks and uncertainties that could cause actual results to differmaterially from those in the forward-looking statements, which may include,but are not limited to, such factors as unanticipated changes in productdemand, increased competition, failure to obtain or maintain intellectualproperty protection, downturns in the Chinese economy, uncompetitive levels ofresearch and development, failure to obtain regulatory approvals, and otherinformation detailed from time to time in the Company's filings and futurefilings with the United States Securities and Exchange Commission. Theforward-looking statements made herein speak only as of the date of this pressrelease and the Company undertakes no duty to update any forward-lookingstatement to conform the statement to actual results or changes in thecompany's expectations.For more information, please contact: China Pharma Holdings, Inc. Sophia Yu Tel: +86-898-6681-1730 Email: [email protected] HC International, Inc. Alan Sheinwald Tel: +1-914-669-0222
SOURCE China Pharma Holdings, Inc.
